{"organizations": [], "uuid": "ff0f69fcbb9c2f9a23a88b575448e70ebd1e0370", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180403.html", "section_title": "Archive News &amp; Video for Tuesday, 03 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/pfizer-divestiture-procter-gamble/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSL4N1RG50P", "country": "US", "domain_rank": 408, "title": "CORRECTED-Pfizer in talks with P&G for consumer health unit sale - CNBC", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.062, "site_type": "news", "published": "2018-04-03T22:48:00.000+03:00", "replies_count": 0, "uuid": "ff0f69fcbb9c2f9a23a88b575448e70ebd1e0370"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/pfizer-divestiture-procter-gamble/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSL4N1RG50P", "ord_in_thread": 0, "title": "CORRECTED-Pfizer in talks with P&G for consumer health unit sale - CNBC", "locations": [], "entities": {"persons": [{"name": "sriraj kalluvila", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "p&g", "sentiment": "negative"}, {"name": "cnbc", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "negative"}, {"name": "manas mishra", "sentiment": "none"}, {"name": "procter & gamble co p&g", "sentiment": "none"}, {"name": "glaxosmithkline", "sentiment": "none"}, {"name": "reckitt benckiser", "sentiment": "none"}, {"name": "johnson & johnson", "sentiment": "none"}, {"name": "pfizer inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Corrects paragraph 3 to say Pfizer is considering options with other drugmakers, not with P&G)\nApril 3 (Reuters) - Pfizer Inc is in talks with Procter & Gamble Co P&G.N for a sale of the U.S. drugmakerâ€™s consumer health business, CNBC reported on Tuesday, citing sources.\nThe companies were far apart on a price for the business, according to the report.\nPfizer is considering other options, including a joint venture with other drugmakers, CNBC said.\nPfizer and P&G could not be immediately reached for comment.\nGlaxoSmithKline, Reckitt Benckiser and Johnson & Johnson have all exited from the bidding process, endangering an auction Pfizer hoped would bring in as much as $20 billion\nReporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-03T22:48:00.000+03:00", "crawled": "2018-04-04T12:34:01.002+03:00", "highlightTitle": ""}